Literature DB >> 4773075

Determination of the acetylator phenotype from the ratio of the urinary excretion of acetylisoniazid to acid-labile isoniazid: a study in Finnish Lapland.

G A Ellard, P T Gammon, H Tiitinen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4773075     DOI: 10.1016/0041-3879(73)90025-1

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


× No keyword cloud information.
  11 in total

1.  Plasma and salivary concentrations of isoniazid in man: preliminary findings in two slow acetylator subjects.

Authors:  H G Boxenbaum; I Berkersky; V Mattaliano; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  Pharmacokinetics of isoniazid metabolism in man.

Authors:  G A Ellard; P T Gammon
Journal:  J Pharmacokinet Biopharm       Date:  1976-04

3.  Hydralazine-induced peripheral neuropathy seen in a Japanese slow acetylator patient.

Authors:  G Tsujimoto; Y Horai; T Ishizaki; K Itoh
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

4.  Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution.

Authors:  A K Karim; M S Elfellah; D A Evans
Journal:  J Med Genet       Date:  1981-10       Impact factor: 6.318

5.  Effect of prednisolone and rifampin on isoniazid metabolism in slow and rapid inactivators of isoniazid.

Authors:  G R Sarma; S Kailasam; N G Nair; A S Narayana; S P Tripathy
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

6.  An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs.

Authors:  G A Ellard; P J Jenner; P A Downs
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

7.  Factors in hydrazine formation from isoniazid by paediatric and adult tuberculosis patients.

Authors:  W L Gent; H I Seifart; D P Parkin; P R Donald; J H Lamprecht
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

8.  The penetration of dapsone, rifampicin, isoniazid and pyrazinamide into peripheral nerves.

Authors:  B W Allen; G A Ellard; P T Gammon; R C King; A C McDougall; R J Rees; A G Weddell
Journal:  Br J Pharmacol       Date:  1975-09       Impact factor: 8.739

Review 9.  Clinical pharmacokinetics of isoniazid.

Authors:  W W Weber; D W Hein
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

10.  Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.

Authors:  Y Horai; T Ishizaki; T Sasaki; G Koya; K Matsuyama; S Iguchi
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.